Literature DB >> 23359452

Hepatocellular carcinoma with blood supply from parasitized omental artery: angiographic appearance and chemoembolization.

Song Gao1, Ren-Jie Yang, Jia-Hong Dong.   

Abstract

OBJECTIVE: To analyze angiographic appearance of hepatocellular carcinoma (HCC) with blood supply from parasitized omental artery (POA), and evaluate the technical feasibility, safety and therapeutic efficacy of chemo-embolization via the POAs.
METHODS: A total of 1,221 HCC patients who had undergone chemoembolization procedures were evaluated retrospectively. The evaluated indexes included the incidence rate of POAs, success rate of superselective catheterization, post-reaction after chemoembolization, and the cumulative survival rates.
RESULTS: Totally 1,221 HCC patients had undergone 3,639 chemoembolization procedures, and 32 patients with POAs were enrolled, with 97 POAs found in 76 angiography procedures, giving an incidence rate of 2.09%. POA was observed mostly at the right lobe and left medial lobe except the segment II, and 62 POAs underwent superselective catheterization with microcatheter, giving a success rate of 63.9%. The angiographic appearance was: (1) hypertrophic POAs participating in tumor staining (n=28); (2) stiff and distorted POA (n=11), displaced due to tumor's oppression (n=8); and (3) defective tumor staining close to either gastrocolic omentum distribution or liver capsule (n=7). In 19 patients, chemoembolization via POAs was performed successfully (A group), while the remaining 13 patients failed (B group). Except 1 acute edema pancreatitis case, no serious complication was recorded. The cumulative survival rates of 6-, 12-, 18- and 24-month were 78.9%, 47.4%, 31.6% and 21.1% respectively for A group; correspondingly, 61.5%, 30.8%, 15.4% and 7.7%% for B group, in which 2 patients died of ruptured HCC.
CONCLUSION: Chemoembolization with microcatheter via POAs is a relatively safe, feasible and valuable method.

Entities:  

Keywords:  Angiography; Chemoembolization; Hepatocellular carcinoma; Omental artery

Year:  2012        PMID: 23359452      PMCID: PMC3555289          DOI: 10.1007/s11670-012-0207-7

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  24 in total

1.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

Review 2.  Hepatocellular carcinoma supplied by the ileocolic branch of the superior mesenteric artery.

Authors:  D K Rajan; V E Ginzburg
Journal:  Clin Radiol       Date:  2005-06       Impact factor: 2.350

3.  Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries.

Authors:  Sung Il Park; Do Yun Lee; Jong Yoon Won; Jong Tae Lee
Journal:  J Vasc Interv Radiol       Date:  2003-04       Impact factor: 3.464

4.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.

Authors:  Chung-Mau Lo; Henry Ngan; Wai-Kuen Tso; Chi-Leung Liu; Chi-Ming Lam; Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

5.  Hepatocellular carcinoma with blood supply from omental branches: treatment with transcatheter arterial embolization.

Authors:  S Miyayama; O Matsui; Y Akakura; T Yamamoto; H Nishida; K Yoneda; K Kawai; H Nishijima
Journal:  J Vasc Interv Radiol       Date:  2001-11       Impact factor: 3.464

6.  Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular carcinoma.

Authors:  Yong-Li Wang; Ming-Hua Li; Ying-Sheng Cheng; Hai-Bing Shi; Hai-Lun Fan
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

7.  Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization.

Authors:  Hyo-Cheol Kim; Jin Wook Chung; Whal Lee; Hwan Jun Jae; Jae Hyung Park
Journal:  Radiographics       Date:  2005-10       Impact factor: 5.333

Review 8.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

Review 9.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

10.  Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma.

Authors:  Jong Yun Won; Do Yun Lee; Jong Tae Lee; Sung Il Park; Myeong-Jin Kim; Hyung Sik Yoo; Sang-Hyun Suh; Sang Joon Park
Journal:  Cardiovasc Intervent Radiol       Date:  2003-03-18       Impact factor: 2.740

View more
  1 in total

1.  Segmental Arterial Mediolysis of Omental Arteries with Haemoperitoneum: Case Report with Embolization of the Left Omental Artery and Brief Review of Literature.

Authors:  Gernot Rott; Frieder Boecker
Journal:  Case Rep Radiol       Date:  2018-07-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.